PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-90.32%
Both yoy net incomes decline, with JD at -49.15%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
24.31%
D&A growth well above JD's 6.27%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-308.12%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.90%
Less SBC growth vs. JD's 7.66%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
300.34%
Working capital change of 300.34% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-83.31%
AR is negative yoy while JD is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
334.43%
Inventory growth of 334.43% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
903.59%
AP growth of 903.59% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
18376.47%
Growth of 18376.47% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
399.83%
Lower 'other non-cash' growth vs. JD's 3324.71%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
155.81%
Operating cash flow growth above 1.5x JD's 102.01%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-1.31%
Both yoy lines negative, with JD at -43.91%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
6.10%
Acquisition growth of 6.10% while JD is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
2.51%
Purchases growth of 2.51% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
920.29%
Liquidation growth of 920.29% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-13.84%
Both yoy lines negative, with JD at -355.43%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
30.67%
We have mild expansions while JD is negative at -83.60%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-275.25%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.